| Old Articles: <Older 6361-6370 Newer> |
|---|
 |
The Motley Fool
June 2, 2010
Rick Steier |
Why Medifast Will Go the Distance The only kind of product designed to fail -- diet products -- are a good route to great returns.   |
CFO
June 1, 2010
Alix Stuart |
"This Is the Era of Smarter Medicine." A prescription-drug provider says it can thrive even as it helps drive down health-care costs. An interview with Richard Rubino, CFO, Medco Health Solutions Inc. |
The Motley Fool
June 1, 2010
Brian Orelli |
Save Your Money, Dendreon As much as doctors would like to prescribe Dendreon's Provenge for their patients, manufacturing limitations will keep demand outpacing supply for awhile. |
The Motley Fool
June 1, 2010
Selena Maranjian |
These Boomer Trends Could Hurt and Help You The aging of America has one financial upside -- there are companies that work hard to make aging easier. |
IEEE Spectrum
June 2010
Prachi Patel |
Diagnostic Contacts A contact lens that tracks ocular pressure may help treat glaucoma |
Chemistry World
June 2010 |
Column: In the pipeline Derek Lowe looks into his crystal ball to see what the future of medicinal chemistry might be |
The Motley Fool
May 28, 2010
Brian Orelli |
Innovators Will Rule the Economic Crisis Roche's CEO says two areas of health care can prosper. I agree. |
The Motley Fool
May 28, 2010
Brian Orelli |
Is It Time to Make Money Investing in Genetic Testing? Easier said than done. |
The Motley Fool
May 28, 2010
Brian Orelli |
How Much Is This Going to Cost J&J? Investors need an answer from Johnson & Johnson about low-quality drugs that were recalled. Is the problem systemic, and if so, how much will it cost the company to fix the problem? |
The Motley Fool
May 28, 2010
Brian Orelli |
This Drug Doesn't Work. But All Is Not Lost. Novartis cancer drug fails one trial, but there's still hope. |
| <Older 6361-6370 Newer> Return to current articles. |
